Quiron Group - International Breast Cancer Center (IBCC), Université Libre de Bruxelles (ULB) - Institute Jules Bordet, Hospital Universitario Virgen del Rocío - Medical Oncology Department, Institut Català d'Oncologia, Hospital Clínico Universitario de Valencia, Queen Mary University of London - Barts ECMC, Leitung Sektion Translationale Gynäkologische Onkologie Nationales Centrum für 27 Tumorerkrankungen und Universitätsfrauenklinik Heidelberg, Vall d'Hebron University Hospital - Breast Cancer Group, Hospital Universitario A Coruña - UGC Oncología Intercentros, Hospital Universitario Virgen de la Victoria, Universidad de Alcalá, IRYCIS, Hospital Universitari Sant Joan de Reus - Department of Medical Oncology, Hospital Clinic of Barcelona - Department of Medical Oncology, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Sorbonne University - Tenon Hospital, Nuclear Medicine and PET Center Department, European Institute of Oncology (IEO) - Division of Medical Senology, Universidade do Porto - Centro Hospitalar, Medica Scientia Innovation Research (MEDSIR), Medica Scientia Innovation Research (MEDSIR), Vall d'Hebron Institute of Oncology, Universidad Catolica - Hospital Arnau de Vilanova and Independent

Queen Mary University of London - Barts ECMC, Peter MacCallum Cancer Centre - Division of Research, Sungkyunkwan University - Division of Hematology-Oncology, Vall d'Hebron Institute of Oncology, University of Ulsan - Department of Oncology, Yonsei University - Yonsei Cancer Center, Karolinska Institutet, Essen-Mitte Kliniken, National Cancer Centre Singapore, Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Merck & Co., Inc., Vall d'Hebron Institute of Oncology and Peter MacCallum Cancer Centre